Cooper Companies | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Abbott USD 50.83B 1.76B 2025-06
Align Technology USD 3.79B 57.74M 2025-03
AtriCure USD 464.49M 9.87M 2025-06
Avanos Medical USD 776.3M 63.1M 2025-06
Bausch Health Companies USD 147M 1.33B 2025-06
Baxter International USD 7.05B 90M 2025-03
Bayer EUR 32.58B 537M 2025-03
Becton, Dickinson and Co. USD 25.24B 36M 2025-03
Boston Scientific USD 22.21B 443M 2025-03
Cooper Companies USD 8.29B 160.6M 2025-04
Dentsply International USD 2.01B 68M 2025-03
Dexcom USD 2.57B 306.5M 2025-06
Edwards Lifesciences USD 10.19B 193.2M 2025-03
Globus Medical USD 4.09B 89.26M 2025-03
Haemonetics USD 820.84M 86.02M 2025-03
Hologic USD 4.84B 223.8M 2025-06
Insulet USD 1.33B 119.1M 2025-03
Integra LifeSciences USD 1.04B 485.48M 2025-06
Intuitive Surgical USD 17.95B 745.4M 2025-06
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merit Medical Systems USD 1.49B 59.62M 2025-06
Novartis USD 44.05B 729M 2024-12
ResMed USD 5.97B 421.73M 2025-06
STAAR Surgical USD 349.97M 47.36M 2025-03
Steris USD 6.62B 187.21M 2025-03
Stryker USD 21.19B 261M 2025-06
Tandem Diabetes Care USD 133.28M 22.01M 2025-06
Teleflex USD 4.24B 147.7M 2025-06
Zimmer Biomet Holdings USD 12.53B 130.5M 2025-06


Cooper Companies Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.